Evaluation of the PKMYT1 inhibitor Lunresertib and the Wee1 inhibitor Debio 0123 as a potential combination treatment in chordoma
<p dir="ltr">To evaluate PKMYT1 inhibition and Wee1 inhibition as a potential combination therapy in chordoma, chordoma cell lines were treated with Lunreseritb and Debio 0123 as single agent treatments and as a combination treatment. Cell lines were seeded in a white-walled 96-well...
Guardado en:
| Autor principal: | |
|---|---|
| Publicado: |
2025
|
| Materias: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|